System-wide approaches to antimicrobial therapy andantimicrobial resistance in the UK: the AMR-X framework

  09 March 2024

Antimicrobial resistance (AMR) poses a threat to human, animal, and environmental health. AMR-X is an AMR learning system that envisions a national network of health systems using data from routine clinical care to optimize antimicrobial use. It integrates traditional research, continuous analysis of pathogens, and clinical outcomes to drive changes in practice and outcomes. AMR-X uses data-to-action systems to evaluate routine care, drive improvements in patient and population health, target investment, and incentivize innovation. All stakeholders co-create AMR-X to protect the public from AMR threats.

Further reading: The Lancet
Author(s): AMR-X Collaborators
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed